• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Stories

Angèle, Subsistence Farmer

Home > Stories

Angèle, Subsistence Farmer

Woman sitting on a bed in a hospital
20 Apr 2013

Musenge Village, Masi Manimba
Democratic Republic of the Congo

Angèle is in her early twenties. She is married and has three children. She and her husband work in the field as subsistance farmers to gather food for their family. In July this year, the sleeping sickness mobile unit paid an important visit to her village to screen the population for the disease. Angèle was diagnosed with late stage sleeping sickness.

Because her husband was ill with measles, Angèle came to the hospital accompanied by her mother to seek treatment. Despite feeling ill, she walked for two days, 60 kilometres, to reach the hospital. It was there that she found out that she was pregnant with her fourth child, and in order to receive treatment with Nifurtimox-Eflornithine Combination Therapy (NECT), she was advised to return for treatment in her second trimester, two months later. ‘I had terrible headaches and had the chills all night long, every night, for 6 months. When the mobile team came to my village I finally found out what was wrong. In my village there are many cases of sleeping sickness. My grandmother had it, my father as well. Both were treated and cured’, she recounted. When Angèle reached her fourth month of pregnancy, she once again prepared for her two day journey by foot to reach Masi Manimba Reference Hospital. She received treatment with NECT and quickly began to feel better. ‘I am near the end of my treatment, and I feel a huge difference. My headaches are almost gone and I no longer have the chills all night’, she said. Angèle will soon return to her family, in a village that fortunately is covered by a mobile unit that conducts active screening for sleeping sickness. Patients such as Angèle, far from reference hospitals, are typically those that may not seek treatment without a clear diagnosis in their village.

Sleeping sickness Democratic Republic of Congo

Read, watch, share

Loading...
News
9 Oct 2026

DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness

Press releases
6 Oct 2026

Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa

Statements
25 Sep 2026

DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly

News
15 Sep 2026

New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D

Hand with lap glove holding a sample with transparent liquid
Publications
8 Sep 2026

Implementing Article 9.5 of the WHO Pandemic Agreement

Viewpoints
28 Aug 2026

How a one-day cure could finally eliminate sleeping sickness in Africa

Stories
27 Aug 2026

Drug discovery explained: Moonshot: open science to prepare for pandemics?

Pictures of patients waiting at the Mycetoma Research Center in Sudan
Stories
20 Aug 2026

Mycetoma at 10: What recognition made possible

VIEW ALL

Help neglected patients

To date, we have delivered seventeen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license